Free Trial

Celsius Holdings, Inc. (NASDAQ:CELH) Stock Holdings Increased by Two Sigma Investments LP

Celsius logo with Consumer Staples background

Two Sigma Investments LP raised its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 264.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 894,158 shares of the company's stock after buying an additional 648,582 shares during the period. Two Sigma Investments LP owned about 0.38% of Celsius worth $23,552,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CELH. Vanguard Group Inc. lifted its position in shares of Celsius by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company's stock valued at $416,517,000 after acquiring an additional 345,837 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Celsius by 11.2% during the fourth quarter. Alliancebernstein L.P. now owns 14,292,123 shares of the company's stock worth $376,455,000 after purchasing an additional 1,444,020 shares during the period. Alyeska Investment Group L.P. lifted its holdings in shares of Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock valued at $181,164,000 after purchasing an additional 2,591,345 shares during the last quarter. FMR LLC boosted its position in shares of Celsius by 64.2% in the 4th quarter. FMR LLC now owns 4,055,148 shares of the company's stock valued at $106,813,000 after purchasing an additional 1,585,839 shares during the period. Finally, Champlain Investment Partners LLC purchased a new position in Celsius in the 4th quarter worth about $85,068,000. Institutional investors and hedge funds own 60.95% of the company's stock.

Insiders Place Their Bets

In other Celsius news, Director Joyce Russell sold 4,000 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the sale, the director now directly owns 19,106 shares of the company's stock, valued at $543,947.82. This represents a 17.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Paul H. Storey sold 10,188 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the sale, the insider now owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. The trade was a 18.36% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.55% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on CELH. B. Riley reaffirmed a "buy" rating and set a $49.00 price objective (up from $44.00) on shares of Celsius in a research note on Friday, February 21st. LADENBURG THALM/SH SH reduced their price target on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Stifel Nicolaus cut their target price on shares of Celsius from $45.00 to $37.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. JPMorgan Chase & Co. raised their target price on Celsius from $39.00 to $44.00 and gave the stock an "overweight" rating in a research report on Friday, May 2nd. Finally, Truist Financial upgraded Celsius from a "hold" rating to a "buy" rating and lifted their price target for the company from $35.00 to $45.00 in a report on Monday, March 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $47.00.

View Our Latest Analysis on Celsius

Celsius Trading Down 3.9%

Shares of NASDAQ:CELH opened at $36.58 on Thursday. Celsius Holdings, Inc. has a 1 year low of $21.10 and a 1 year high of $98.85. The firm has a fifty day moving average price of $35.79 and a 200 day moving average price of $30.06. The stock has a market capitalization of $9.43 billion, a PE ratio of 83.14, a P/E/G ratio of 2.90 and a beta of 1.65.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a return on equity of 51.89% and a net margin of 10.70%. The company had revenue of $329.28 million for the quarter, compared to the consensus estimate of $349.09 million. During the same quarter last year, the company posted $0.27 EPS. The business's revenue was down 7.4% compared to the same quarter last year. On average, sell-side analysts forecast that Celsius Holdings, Inc. will post 0.89 earnings per share for the current fiscal year.

Celsius Company Profile

(Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Articles

Institutional Ownership by Quarter for Celsius (NASDAQ:CELH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Celsius Right Now?

Before you consider Celsius, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.

While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines